GetTopicDetailResponse(id=a6d41280164f, topicName=埃諾格魯肽, introduction=, content=GLP-1受體激動(dòng)劑 埃諾格魯肽, image=null, comments=0, allHits=177, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sun Jun 22 23:53:44 CST 2025, time=2025-06-22, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=505785, tagList=[TagDto(tagId=505785, tagName=埃諾格魯肽)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2270458, encodeId=b1d822e045822, content=<a href='/topic/show?id=bb0e8081b2' target=_blank style='color:#2F92EE;'>#GLP-1受體激動(dòng)劑#</a> <a href='/topic/show?id=a6d41280164f' target=_blank style='color:#2F92EE;'>#埃諾格魯肽#</a>, objectTitle=新藥每周一次，93%中國患者成功減重，還降三高、尿酸和脂肪肝！紀(jì)立農(nóng)教授領(lǐng)銜研究登《柳葉刀》子刊, objectType=article, longId=883566, objectId=8dd3883566a1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240526/1716738097277_92910.jpg, objectUrl=/article/show_article.do?id=8dd3883566a1, replyNumber=0, likeNumber=26, createdTime=2025-06-22, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8dd3883566a1, moduleTitle=新藥每周一次，93%中國患者成功減重，還降三高、尿酸和脂肪肝！紀(jì)立農(nóng)教授領(lǐng)銜研究登《柳葉刀》子刊, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8dd3883566a1)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-06-22發(fā)表于上海
